Colgate-Palmolive (CL) Reports In-Line Q3 EPS; Raises FY Organic Sales Guidance

Colgate-Palmolive (NYSE: CL) reported Q3 EPS of $0.74, in-line with the analyst estimate of $0.74. Revenue for the quarter came in at $4.46 billion versus the consensus estimate of $4.48 billion.

GUIDANCE:

• The Company now expects net sales growth to be in the middle of the 1% to 4% range, including an approximately 5% negative impact from foreign exchange and a modest benefit from the Red Collar acquisition.
• The Company raised its organic sales growth guidance for the year from 5% to 7% to 6% to 7%.
• On a GAAP basis, the Company still expects a decline in gross profit margin and double-digit earnings-per-share growth, and now expects advertising investment to be roughly flat.
• On a non-GAAP (Base Business) basis, the Company still expects a decline in gross profit margin and now expects roughly flat advertising investment and a 7% to 8% earnings-per-share decline reflecting the incremental negative impact from foreign exchange due to the move in exchange rates since our second quarter earnings release.

For earnings history and earnings-related data on Colgate-Palmolive (CL) click here.

You May Also Be Interested In

• Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
• Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
• Stratasys (SSYS) Tops Q2 EPS by 2c ;; Offers Guidance